212 related articles for article (PubMed ID: 24532498)
1. Charlson comorbidity index is an important prognostic factor for long-term survival outcomes in Korean men with prostate cancer after radical prostatectomy.
Lee JY; Lee DH; Cho NH; Rha KH; Choi YD; Hong SJ; Yang SC; Cho KS
Yonsei Med J; 2014 Mar; 55(2):316-23. PubMed ID: 24532498
[TBL] [Abstract][Full Text] [Related]
2. Impact of Charlson comorbidity index varies by age in patients with prostate cancer treated by radical prostatectomy: a competing risk regression analysis.
Lee JY; Lee DH; Cho NH; Rha KH; Choi YD; Hong SJ; Yang SC; Cho KS
Ann Surg Oncol; 2014 Feb; 21(2):677-83. PubMed ID: 24145996
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer-specific survival in men treated with hormonal therapy after failure of radical prostatectomy.
Porter CR; Gallina A; Kodama K; Gibbons RP; Correa R; Perrotte P; Karakiewicz PI
Eur Urol; 2007 Aug; 52(2):446-52. PubMed ID: 17140724
[TBL] [Abstract][Full Text] [Related]
4. Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy.
Sivaraman A; Ordaz Jurado G; Cathelineau X; Barret E; Dell'Oglio P; Joniau S; Bianchi M; Briganti A; Spahn M; Bastian P; Chun J; Chlosta P; Gontero P; Graefen M; Jeffrey Karnes R; Marchioro G; Tombal B; Tosco L; van der Poel HH; Sanchez-Salas R
World J Urol; 2016 Oct; 34(10):1367-72. PubMed ID: 26897499
[TBL] [Abstract][Full Text] [Related]
5. Effects of age and comorbidity on survival vary according to risk grouping among patients with prostate cancer treated using radical prostatectomy: A retrospective competing-risk analysis from the K-CaP registry.
Hah YS; Lee KS; Choi IY; Lee JY; Hong JH; Kim CS; Lee HM; Hong SK; Byun SS; Lee SH; Rha KH; Chung BH; Koo KC
Medicine (Baltimore); 2018 Oct; 97(42):e12766. PubMed ID: 30334964
[TBL] [Abstract][Full Text] [Related]
6. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
7. Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses.
Koo KC; Cho JS; Bang WJ; Lee SH; Cho SY; Kim SI; Kim SJ; Rha KH; Hong SJ; Chung BH
Cancer Res Treat; 2018 Jan; 50(1):129-137. PubMed ID: 28279064
[TBL] [Abstract][Full Text] [Related]
8. Prediction of mortality after radical prostatectomy by Charlson comorbidity index.
Guzzo TJ; Dluzniewski P; Orosco R; Platz EA; Partin AW; Han M
Urology; 2010 Sep; 76(3):553-7. PubMed ID: 20627284
[TBL] [Abstract][Full Text] [Related]
9. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
Briganti A; Spahn M; Joniau S; Gontero P; Bianchi M; Kneitz B; Chun FK; Sun M; Graefen M; Abdollah F; Marchioro G; Frohenberg D; Giona S; Frea B; Karakiewicz PI; Montorsi F; Van Poppel H; Jeffrey Karnes R;
Eur Urol; 2013 Apr; 63(4):693-701. PubMed ID: 22959192
[TBL] [Abstract][Full Text] [Related]
10. The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression.
Pascale M; Azinwi CN; Marongiu B; Pesce G; Stoffel F; Roggero E
BMC Cancer; 2017 Sep; 17(1):651. PubMed ID: 28923109
[TBL] [Abstract][Full Text] [Related]
11. Impact of surgical margin status on prostate-cancer-specific mortality.
Chalfin HJ; Dinizo M; Trock BJ; Feng Z; Partin AW; Walsh PC; Humphreys E; Han M
BJU Int; 2012 Dec; 110(11):1684-9. PubMed ID: 22788795
[TBL] [Abstract][Full Text] [Related]
12. Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.
Lee JY; Kang HW; Rha KH; Cho NH; Choi YD; Hong SJ; Cho KS
J Cancer Res Clin Oncol; 2016 Apr; 142(4):849-58. PubMed ID: 26660495
[TBL] [Abstract][Full Text] [Related]
13. Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients.
Park JW; Koh DH; Jang WS; Lee JY; Cho KS; Ham WS; Rha KH; Jung WH; Hong SJ; Choi YD
PLoS One; 2018; 13(6):e0199365. PubMed ID: 29924851
[TBL] [Abstract][Full Text] [Related]
14. Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5-4 ng/ml.
Qi P; Tsivian M; Abern MR; Bañez LL; Tang P; Moul JW; Polascik TJ
Urol Oncol; 2013 Nov; 31(8):1527-32. PubMed ID: 22795501
[TBL] [Abstract][Full Text] [Related]
15. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival of patients aged 80 years or older treated with radical prostatectomy for prostate cancer.
Dell'Oglio P; Zaffuto E; Boehm K; Trudeau V; Larcher A; Tian Z; Moschini M; Shariat SF; Graefen M; Saad F; Capitanio U; Briganti A; Montorsi F; Karakiewicz PI
Eur J Surg Oncol; 2017 Aug; 43(8):1581-1588. PubMed ID: 28330822
[TBL] [Abstract][Full Text] [Related]
17. Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification.
Ploussard G; Masson-Lecomte A; Beauval JB; Ouzzane A; Bonniol R; Buge F; Fadli S; Rouprêt M; Rebillard X; Gaschignard N; Pfister C; Villers A; Soulié M; Salomon L;
Urology; 2011 Sep; 78(3):607-13. PubMed ID: 21783233
[TBL] [Abstract][Full Text] [Related]
18. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
19. The impact of preoperative erectile dysfunction on survival after radical prostatectomy.
Han M; Trock BJ; Partin AW; Humphreys EB; Bivalacqua TJ; Guzzo TJ; Walsh PC
BJU Int; 2010 Dec; 106(11):1612-7. PubMed ID: 20590546
[TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
